Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-07T14:04:33.258Z Has data issue: false hasContentIssue false

The antileishmanial activity of xanthohumol is mediated by mitochondrial inhibition

Published online by Cambridge University Press:  12 December 2016

LIANET MONZOTE
Affiliation:
Department of Biomedical Sciences, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, A-1210 Vienna, Veterinärplatz 1, Austria Parasitology Department, Institute of Tropical Medicine ‘Pedro Kouri’, 11500 Havana, Marianao 13, PO Box 601, Cuba
ALEXANDRA LACKOVA
Affiliation:
Department of Biomedical Sciences, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, A-1210 Vienna, Veterinärplatz 1, Austria Department of Pharmaceutical Chemistry, Division of Clinical Pharmacy and Diagnostics, University of Vienna, A-1090 Vienna, Althanstraße 14, Austria
KATRIN STANIEK
Affiliation:
Department of Biomedical Sciences, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, A-1210 Vienna, Veterinärplatz 1, Austria
SILVIA STEINBAUER
Affiliation:
Department of Biomedical Sciences, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, A-1210 Vienna, Veterinärplatz 1, Austria
GERALD PICHLER
Affiliation:
Department of Biomedical Sciences, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, A-1210 Vienna, Veterinärplatz 1, Austria
WALTER JÄGER
Affiliation:
Department of Pharmaceutical Chemistry, Division of Clinical Pharmacy and Diagnostics, University of Vienna, A-1090 Vienna, Althanstraße 14, Austria
LARS GILLE*
Affiliation:
Department of Biomedical Sciences, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, A-1210 Vienna, Veterinärplatz 1, Austria
*
*Corresponding author: Department of Biomedical Sciences, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, A-1210 Vienna, Veterinärplatz 1, Austria. E-mail: Lars.Gille@vetmeduni.ac.at

Summary

Xanthohumol (Xan) is a natural constituent of human nutrition. Little is known about its actions on leishmanial parasites and their mitochondria as putative target. Therefore, we determined the antileishmanial activity of Xan and resveratrol (Res, as alternative compound with antileishmanial activity) with respect to mitochondria in Leishmania amazonensis promastigotes/amastigotes (LaP/LaA) in comparison with their activity in peritoneal macrophages from mouse (PMM) and macrophage cell line J774A.1 (J774). Mechanistic studies were conducted in Leishmania tarentolae promastigotes (LtP) and mitochondrial fractions isolated from LtP. Xan and Res demonstrated antileishmanial activity in LaA [half inhibitory concentration (IC50): Xan 7 µ m, Res 14 µ m]; while they had less influence on the viability of PMM (IC50: Xan 70 µ m, Res >438 µ m). In contrast to Res, Xan strongly inhibited oxygen consumption in Leishmania (LtP) but not in J774 cells. This was based on the inhibition of the mitochondrial electron transfer complex II/III by Xan, which was less pronounced with Res. Neither Xan nor Res increased mitochondrial superoxide release in LtP, while both decreased the mitochondrial membrane potential in LtP. Bioenergetic studies showed that LtP mitochondria have no spare respiratory capacity in contrast to mitochondria in J774 cells and can therefore much less adapt to stress by mitochondrial inhibitors, such as Xan. These data show that Xan may have antileishmanial activity, which is mediated by mitochondrial inhibition.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2016 
Figure 0

Fig. 1. Molecular structures of resveratrol (Res) and xanthohumol (Xan).

Figure 1

Table 1. Influence of pentamidine isethionate (Pen, reference drug), resveratrol (Res) and xanthohumol (Xan) on the viability of L. amazonensis amastigotes (LaA) and peritoneal macrophages from mouse (PMM)

Figure 2

Table 2. Influence of pentamidine isethionate (Pen, reference drug), resveratrol (Res) and xanthohumol (Xan) on the viability of L. amazonensis promastigotes (LaP), L. tarentolae promastigotes (LtP) and J774 macrophages

Figure 3

Fig. 2. Oxygen consumption of L. tarentolae promastigotes in yeast extract medium and its inhibition by resveratrol (Res), xanthohumol (Xan) and pentamidine (Pen). Xan exhibited an IC50 value of 16 ± 1 µm, while Res and Pen showed 16 and 28% inhibition at 200 µm. Non-inhibited oxygen consumption of cells was 9·3 nmol O min−1 (108 cells)−1, which was set to 100%. Data represent mean ± s.e. from four independent experiments.

Figure 4

Table 3. Influence of pentamidine isethionate (Pen, reference drug), resveratrol (Res) and xanthohumol (Xan) on the oxygen consumption of L. tarentolae promastigotes (LtP) and J774 macrophages

Figure 5

Fig. 3. Complex II activity of L. tarentolae promastigote mitochondria and its inhibition by resveratrol (Res) and xanthohumol (Xan). Xan exhibited an IC50 value of 45·1 ± 3·3 µm. Res showed an inhibition of 25% at 150 µm. Non-inhibited complex II activity of mitochondria (0·08 mg protein mL−1) was 6·95 nmol min−1 mL−1, which was set to 100%. Data represent mean ± s.d. from three independent experiments.

Figure 6

Table 4. Inhibition of complex II activities in mitochondrial fractions from different species by resveratrol (Res) and xanthohumol (Xan)

Figure 7

Fig. 4. Complex III activity of L. tarentolae promastigote mitochondria and its inhibition by resveratrol (Res) and xanthohumol (Xan). Xan exhibited an IC50 value of 58·2 ± 3·7 µm. Res showed no inhibition at 300 µm. Non-inhibited complex III activity of mitochondria (0·04 mg protein mL−1) was 6·31 nmol min−1 mL−1, which was set to 100%. Data represent mean ± s.d. from three independent experiments.

Figure 8

Table 5. Inhibition of complex III activities in mitochondrial fractions from different species by resveratrol (Res) and xanthohumol (Xan)

Figure 9

Fig. 5. CMH oxidation by L. tarentolae promastigotes (5 × 108 cells mL−1, 17 µL) in the presence of resveratrol (Res, 100 µm), xanthohumol (Xan, 100 µm) and AA (5 µm) was measured by ESR spectroscopy in oxygen-permeable Teflon tubes. ‘Cells only’ samples contained the corresponding amount of vehicle (max. 2% DMSO) used for xenobiotics. Buffer (Bu) samples containing vehicle were prepared without cells. Relative changes of CMH oxidation in comparison with ‘Cells only’ samples (100%) were: Res (72 ± 5%), Xan (32 ± 2%) and AA (145 ± 27%). Data represent mean ± s.d. from quadruplicates and * indicates statistically significant differences on the level P < 0·05 with respect to ‘Cells only’ samples.

Figure 10

Fig. 6. Mitochondrial membrane potential in L. tarentolae promastigotes. 5 × 107 cells mL−1 were suspended in the presence of resveratrol (Res, 200 µm), xanthohumol (Xan, 200 µm), valinomycin (Val, 10 µm), carbonyl cyanide m-chlorophenyl hydrazone (CCCP, 0·5 µm), oligomycin (Oligo, 10 µm) and antimycin A (AA, 0·1 µm). Aggregates of JC-1 (15 µm) were measured by fluorescence (λEx = 485 nm, λEm = 590 nm). The fluorescence of the control cells was set to 100%. Data represent mean ± s.d. from quadruplicates and * indicates statistically significant differences on the level P < 0·05 with respect to control.

Figure 11

Fig. 7. Oxygen consumption of L. tarentolae promastigotes (LtP) and J774 macrophages in the absence and presence of inhibitors for bioenergetic characterization. Measurements were performed in Oxoplates with 1 × 108 cells mL−1 for LtP (A) or with 8 × 104 cells mL−1 for J774 (B). Basal oxygen consumption was assessed in the absence of inhibitors/uncouplers (cells). The proton leak rate of mitochondrial membranes was determined in the presence of the ATP synthase inhibitor oligomycin (Oligo, 5 µm). To obtain the maximally uncoupled respiration different Oligo/uncoupler mixtures were applied (5 µm Oligo + 100 µm DNP, 5 µm Oligo + 0·5 µm CCCP, 5 µm Oligo + 1 µm CCCP). Non-mitochondrial oxygen consumption was measured in the presence of 4 µm rotenone (Rot) + 4 µm antimycin A (AA). All measurements were performed in quadruplicates and data represent mean ± s.d.

Figure 12

Table 6. Bioenergetic parameters of L. tarentolae promastigotes (LtP) and J774 macrophages derived from experiments shown in Fig. 7 using the highest uncoupler-stimulated oxygen consumption rates (LtP: at 1 µm CCCP, J774: at 100 µm DNP) for calculation